ProChoice Herbals

pch cataloge logo

Backed by science- Health Canada approved - proven results

Did you know ProChoice Herbals is a superior supplement line, that was created and developed
​by Naturopathic Doctors here at Choice Nutrition? 

Shop Prochoice Herbals

ProChoice Herbals

ProChoice Herbals is a unique line of highly effective supplements, that is exclusively available at Choice Nutrition Centres.

The formulas are specially developed by Choice Nutrition’s Naturopathic Physicians, Integrative Microscopists and Master Herbalists, based on over 25 years of experience and expertise. The formulations have been designed to fill specific requirements in innovative medicinal wellness plans at cost effective pricing to our clients.

ProChoice Herbal products are formulated using only individually selected, purest and most potent components. All ingredients undergo extensive screening for bacteria, mold & yeast, pesticides and heavy metals.

Shop Now

TRANSPARENCY DISCLAIMER

Recommendations made by Naturopathic Doctors employed at Choice Nutrition are for your specific presenting healthcare concerns and are based on dosage and quality of products carried here at Choice Nutrition; however you are under no obligation to purchase these products here and our Naturopathic Doctors have no financial involvement with treatment plan recommendations. Thank you.

We invite you to get to know our ProChoice Herbals line, and to learn about each product's action and its ingredients.

Prochoice Herbals

References

  1. Kaneno R, Fontanari LM, Santos SA, et al. Effect of extracts from Brazilian sun-mushroom (Agaricus blazei) on the NK activity and lymphoproliferative responsiveness of Ehrlich tumor-bearing mice. Food Chem Toxicol 2004;42:909-16.
  2. Kobayashi H, Yoshida R, Kanada Y, et al. Suppressing effects of daily oral supplementation of beta-glucan extracted from Agaricus blazei Murill on spontaneous and peritoneal disseminated metastasis in mouse model. J Cancer Res Clin Oncol 2005;131:527-38.
  3. Kim YW, Kim KH, Choi HJ, Lee DS. Anti-diabetic activity of beta-glucans and their enzymatically hydrolysed oligosaccharides from Agaricus blazei. Biotechnol Lett 2005;27:483-7.
  4. Hsu CH, Liao YL, Lin SC, et al. The mushroom Agaricus Blazei Murill in combination with metformin and gliclazide improves insulin resistance in type 2 diabetes: a randomized, double-blinded, and placebo-controlled clinical trial. J Altern Complement Med 2007;13:97-102.
  5. Vincent M, Philippe E, Everard A, et al. Dietary supplementation with Agaricus blazei Murill extract prevents diet-induced obesity and insulin resistance in rats. Obesity (Silver Spring) 2013;21(3):553-61.

  1. Safayhi, H., Sailer, E. R., and Ammon, H. P. Mechanism of 5-lipoxygenase inhibition by acetyl-11-keto-beta-boswellic acid. Mol.Pharmacol. 1995;47(6):1212-1216.
  2. Safayhi, H., Mack, T., Sabieraj, J., Anazodo, M. I., Subramanian, L. R., and Ammon, H. P. Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase. J Pharmacol.Exp.Ther 1992;261(3):1143-1146.
  3. Sengupta K, Alluri KV, Satish AR, et al. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin. Arthritis Res Ther 2008;10:R85.
  4. Sengupta K, Krishnaraju AV, Vishal AA, et al. Comparative efficacy and tolerability of 5-Loxin and Aflapin against osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical study. Int J Med Sci 2010;7:366-77.
  5. Vishal AA, Mishra A, Raychaudhuri SP. A double-blind, randomized, placebo controlled clinical study evaluates the early efficacy of aflapin in subjects with osteoarthritis of knee. Int J Med Sci 2011;8:615-22.
  6. Gupta I, Parihar A, Malhotra P, et al. Effects of Boswellia serrata gum resin in patients with ulcerative colitis. Eur J Med Res 1997;2:37-43.
  7. Amalraj A, Varma K, Jacob J, et al. A novel highly bioavailable curcumin formulation improves symptoms and diagnostic indicators in rheumatoid arthritis patients: A randomized, double-blind, placebo-controlled, two-dose, three-arm, and parallel-group study. J Med Food. 2017;20(10):1022-1030.
  8. Funk, J. L., Frye, J. B., Oyarzo, J. N., Kuscuoglu, N., Wilson, J., McCaffrey, G., Stafford, G., Chen, G., Lantz, R. C., Jolad, S. D., Solyom, A. M., Kiela, P. R., and Timmermann, B. N. Efficacy and mechanism of action of turmeric supplements in the treatment of experimental arthritis. Arthritis Rheum. 2006;54(11):3452-3464.
  9. Belcaro G, Cesarone MR, Dugall M, et al. Efficacy and safety of Meriva, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. Alt Med Rev 2010:15:337-4.
  10. Belcaro, G., Cesarone, M. R., Dugall, M., Pellegrini, L., Ledda, A., Grossi, M. G., Togni, S., and Appendino, G. Product-evaluation registry of Meriva(R), a curcumin-phosphatidylcholine complex, for the complementary management of osteoarthritis. Panminerva Med 2010;52(2 Suppl 1):55-62.
  11. Piscoya J, Rodriguez Z, Bustamante SA, et al. Efficacy and safety of freeze-dried cat’s claw in osteoarthritis of the knee: mechanisms of action of the species Uncaria guianensis. Inflamm Res 2001;50:442-448.
  12. Mur E, Hartig F, Eibl G, Schirmer M. Randomized double blind trial of an extract from the pentacyclic alkaloid-chemotype of uncaria tomentosa for the treatment of rheumatoid arthritis. J Rheumatol 2002;29:678-81.
  13. Leblan D, Chantre P, Fournié B. Harpagophytum procumbens in the treatment of knee and hip osteoarthritis. Four-month results of a prospective, multicenter, double-blind trial versus diacerhein. Joint Bone Spine. 2000;67(5):462-7.
  14. Chrubasik S, Zimpfer C, Schütt U, Ziegler R. Effectiveness of Harpagophytum procumbens in treatment of acute low back pain. Phytomedicine. 1996 May;3(1):1-10. doi: 10.1016/S0944-7113(96)80003-1. PMID: 23194854.
  15. Ako, H., Cheung, A. H., and Matsuura, P. K. Isolation of a fibrinolysis enzyme activator from commercial bromelain. Arch Int Pharmacodyn.Ther 1981;254(1):157-167.
  16. Lotz-Winter, H. On the pharmacology of bromelain: an update with special regard to animal studies on dose-dependent effects. Planta Med 1990;56(3):249-253.
  17. Taussig SJ, Batkin S. Bromelain, the enzyme complex of pineapple (Ananas comosus) and its clinical application. An update. J Ethnopharmacol 1988;22:191-203.
  18. Masson M. [Bromelain in blunt injuries of the locomotor system. A study of observed applications in general practice]. Fortschr Med 1995;113:303-6.
  19. Gumina S, Passaretti D, Gurzì MD, et al. Arginine L-alpha-ketoglutarate, methylsulfonylmethane, hydrolyzed type I collagen and bromelain in rotator cuff tear repair: a prospective randomized study. Curr Med Res Opin. 2012 Nov;28:1767-74.
  20. Notarnicola A, Pesce V, Vicenti G, et al. SWAAT study: extracorporeal shock wave therapy and arginine supplementation and other nutraceuticals for insertional Achilles tendinopathy. Adv Ther. 2012 Sep;29:799-814.
  21. Usha PR, Naidu MU. Randomised, Double-Blind, Parallel, Placebo-Controlled Study of Oral Glucosamine, Methylsulfonylmethane and their Combination in Osteoarthritis. Clin Drug Investig. 2004;24(6):353-63.
  22. Kim LS, Axelrod LJ, Howard P, et al. Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial. Osteoarthritis Cartilage 2006;14:286-94.
  23. Brien S, Prescott P, Lewith G. Meta-analysis of the related nutritional supplements dimethyl sulfoxide and methylsulfonylmethane in the treatment of osteoarthritis of the knee. Evid Based Complement Alternat Med 2009 May 27.
  24. Debbi EM, Agar G, Fichman G, et al. Efficacy of methylsulfonylmethane supplementation on osteoarthritis of the knee: a randomized controlled study. BMC Complement Altern Med. 2011 Jun 27;11:50.
  25. Murav’ev IuV, Venikova MS, Pleskovskaia GN, et al. Effect of dimethyl sulfoxide and dimethyl sulfone on a destructive process in the joints of mice with spontaneous arthritis. Patol Fiziol Eksp Ter 1991;37-9.
  26. Torella M, Del Deo F, Grimaldi A, et al. Efficacy of an orally administered combination of hyaluronic acid, chondroitin sulfate, curcumin and quercetin for the prevention of recurrent urinary tract infections in postmenopausal women. Eur J Obstet Gynecol Reprod Biol. 2016;207:125-128.
  27. Javadi F, Ahmadzadeh A, Eghtesadi S, et al. The effect of quercetin on inflammatory factors and clinical symptoms in women with rheumatoid arthritis: A double-blind, randomized controlled trial. J Am Coll Nutr. 2017;36(1):9-15.
  28. Hee-ju P, Chang-Min L, In Duk J, et al. Quercetin regulates Th1/Th2 balance in a murine model of asthma. International Immunopharmacology. 2009; 9(3): 261-267.
  29. Rogerio AP, Kanashiro C, et al. Anti-inflammatory activity of quercetin and isoquercetin in experimental murine allergic asthma. Inflammation Research. 2007; 56(10): 402-408.
  30. Joskova M, Franova S, Sadlonova V. Acute bronchodilator
  1. Omura Y, et al. Caprylic acid in the effective treatment of intractable medical problems of frequent urination, incontinence, chronic upper respiratory infection, root canalled tooth infection, ALS, etc, caused by asbdestos & mixed infections of Candida albicans, Helicobacter pylori & cytomegalovirus with or without other microorganisms & Mercury. Acupunct Electrother Res. 2011;36(1-2): 19-64.
  2. Huang WC, et al. Anti-bacterial and anti-inflammatory properties of capric acid against Propionibacterium acnes: a comparative study with lauric acid. J Dermatol Sci. 2014;73(3): 232-240.
  3. Bergsson G, Arnfinnsson J, Steingrímsson O, Thormar H. In vitro killing of Candida albicans by fatty acids and monoglycerides. Antimicrob Agents Chemother. 2001 Nov;45(11):3209-12.
  4. Orekhov AN, Sobenin IA, Korneev NV, et al. Anti-atherosclerotic therapy based on botanicals. Recent Pat Cardiovasc Drug Discov 2013;8(1):56-66.
  5. Steiner M, Khan AH, Holbert D, Lin RI. A double-blind crossover study in moderately hypercholesterolemic men that compared the effect of aged garlic extract and placebo administration on blood lipids. Am J Clin Nutr 1996;64:866-70.
  6. Holzgartner H, Schmidt U, Kuhn U. Comparison of the efficacy and tolerance of a garlic preparation vs. bezafibrate. Arzneimittelforschung 1992;42:1473-7.
  7. Berspalov, V. G., Shcherbakov, A. M., Kalinovskii, V. P., Novik, V. I., Chepik, O. F., Aleksandrov, V. A., Sobenin, I. A., and Orekhov, A. N. [Study of the antioxidant drug “Karinat” in patients with chronic atrophic gastritis]. Vopr.Onkol. 2004;50(1):81-85.
  8. Pinto E, Vale-Silva L, Cavaleiro C, Salgueiro L. Antifungal activity of the clove essential oil from Syzygium aromaticum on Candida, Aspergillus and dermatophyte species. J Med Microbiol. 2009 Nov;58(Pt 11):1454-1462.
  9. da Silva CR, S Campos R, de A Neto JB, Sampaio LS, do Nascimento FB, do Av Sá LG, Cândido TM, Magalhães HI, da Cruz EH, da Silva Júnior EN, de Moraes MO, Cavalcanti BC, Silva J, Marinho ES, Júnior HV. Antifungal activity of β-lapachone against azole-resistant Candida spp. and its aspects upon biofilm formation. Future Microbiol. 2020 Oct;15:1543-1554.
  10. Hacioglu M, Oyardi O, Kirinti A. Oregano essential oil inhibits Candida spp. biofilms. Z Naturforsch C J Biosci. 2021 Apr 29;76(11-12):443-450
  1. Ahee P, Crowe AV. The management of hyperkalaemia in the emergency department. J Accid Emerg Med 2000;17:188-91.
  2. Tarleton EK, Littenberg B, MacLean CD, Kennedy AG, Daley C. Role of magnesium supplementation in the treatment of depression: a randomized clinical trial. PLoS One. 2017 Jun 27;12(6):e0180067.
  3. Anderson PO, Knoben JE. Handbook of Clinical Drug Data. 8th ed. Stamford, CT: Appleton & Lange, 1997.
  4. Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia 1996;16:257-63.
  5. Demirkaya S, Dora B, Topcuoglu MA, et al. A comparative study of magnesium, flunarizine and amitriptyline in the prophylaxis of migraine. J Headache Pain 2000;1:179-86.
  6. Sanjuliani AF, de Abreu Fagundes VG, Francischetti EA. Effects of magnesium on blood pressure and intracellular ion levels of Brazilian hypertensive patients. Int J Cardiol 1996;56:177-83.
  7. Widman L, Wester PO, Stegmayr BK, et al. The dose-dependent reduction in blood pressure through administration of magnesium. A double blind placebo controlled cross-over study. Am J Hypertens 1993;6:41-5.
  8. Reeves PG, DeMars LC. Copper deficiency reduces Iron absorption and biological half life in male rats. J Nurtition. 2004; 134(8): 1953-7.
  9. Scheiber IF, Mercer JF, Dringen R. Metabolism and functions of copper in brain. Prog Neurobiol. 2014; 116: 33-57.
  10. Percival SS. Neutropenia caused by copper deficiency: possible mechanisms of action. Nutr Rev. 1995; 53(3): 59-66.
  11. Gordon SA, Lominadze D, et al. Impaired deformability of copper-deficient neutrophils. Exp Biol Med. 2005; 230(8): 543-8.
  12. Mossad SB, Macknin ML, Medendorp SV, Mason P. Zinc gluconate lozenges for treating the common cold. A randomized, double-blind, placebo-controlled study. Ann Intern Med 1996;125:81-8.
  13. Al-Nakib W, Higgins PG, Barrow I, et al. Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges. J Antimicrob Chemother 1987;20:893-901.
  14. Prasad AS, Fitzgerald JT, Bao B, et al. Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2000;133:245-52.
  15. Attia EA, Belal DM, El Samahy MH, El Hamamsy MH. A pilot trial using topical regular crystalline insulin vs. aqueous zinc solution for uncomplicated cutaneous wound healing: Impact on quality of life. Wound Repair Regen. 2014 Jan-Feb;22(1):52-7.
  16. Lee NA, Reasner CA. Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM. Diabetes Care 1994;17:1449-52.
  17. Rabinovitz H, Friedensohn A, Leibovitz A, et al. Effect of chromium supplementation on blood glucose and lipid levels in type 2 diabetes mellitus elderly patients. Int J Vitam Nutr Res 2004;74:178-82.
  18. Martin J, Wang ZQ, Zhang XH, et al. Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes. Diabetes Care 2006;29:1826-32.
  19. Whelton PK, He J, Cutler JA, et al. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA 1997;277:1624-32.
  20. Poorolajal J, Zeraati F, Soltanian AR, Sheikh V, Hooshmand E, Maleki A. Oral potassium supplementation for management of essential hypertension: a meta-analysis of randomized controlled trials. PLoS One 2017 Apr 18;12(4):e1074967
  21. Lockless SW, Zhou M, MacKinnon R. Structural and thermodynamic properties of selective ion binding in a K+ channel. Plos Biol. 2007; 5(5): e121.
  22. Zenk, J. L., Helmer, T. R., Kassen, L. J., and Kuskowski, M. A. The effect of 7-KETO NATURALEAN on weight loss: a randomized, double-blind, placebo-controlled trial. Current Therapeutic Research (CURR THER RES) 2002;63(4):263-272.
  23. Keen CL, Ensunsa JL, Watson MH, et al. (1999) Nutritional aspects of manganese from experimental studies. Neurotoxicology 20, 213–223.
  24. Szentmihalyi K, Vinkler P, Fodor J, et al. (2006) The role of manganese in the human organism. Orv Hetil 147, 2027–2030.
  25. Bahn Chair RS1, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, Laurberg P, McDougall IR, Montori VM, Rivkees SA, Ross DS, Sosa JA, Stan MN; American Thyroid Association; American Association of Clinical Endocrinologists. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid. 2011 Jun;21(6):593-646.
  26. Battin EE, Brumaghim JL. Antioxidant activity of Sulfur and Selenium: A review of reactive oxygen species scavenging, glutathione peroxidase, and metal-binding antioxidant mechanisms. Cell Biochemistry and Biophysics. 2009; 55(1): 1-23.
  1. Orekhov AN, Sobenin IA, Korneev NV, et al. Anti-atherosclerotic therapy based on botanicals. Recent Pat Cardiovasc Drug Discov 2013;8(1):56-66.
  2. Steiner M, Khan AH, Holbert D, Lin RI. A double-blind crossover study in moderately hypercholesterolemic men that compared the effect of aged garlic extract and placebo administration on blood lipids. Am J Clin Nutr 1996;64:866-70.
  3. Holzgartner H, Schmidt U, Kuhn U. Comparison of the efficacy and tolerance of a garlic preparation vs. bezafibrate. Arzneimittelforschung 1992;42:1473-7.
  4. Berspalov, V. G., Shcherbakov, A. M., Kalinovskii, V. P., Novik, V. I., Chepik, O. F., Aleksandrov, V. A., Sobenin, I. A., and Orekhov, A. N. [Study of the antioxidant drug “Karinat” in patients with chronic atrophic gastritis]. Vopr.Onkol. 2004;50(1):81-85.
  5. Singh BB, et al. The effectiveness of Commiphora mukul for osteoarthritis of the knee: an outcomes study. Altern Ther Health med. 2003; 9(3): 74-9.
  6. Mahesh S, Pandit M, and Hakala C. A study of Shuddha Guggulu on rheumatoid arthritis. Rheumatism 1981;16(2):54-67.
  7. Antonio J, Colker CM, Torina GC, et al. Effects of a standardized guggulsterone phosphate supplement on body composition in overweight adults: a pilot study. Curr Ther Res 1999;60:220-7.
  8. Singh RB, Niaz MA, Ghosh S. Hypolipidemic and antioxidant effects of Commiphora mukul as an adjunct to dietary therapy in patients with hypercholesterolemia. Cardiovasc Drugs Ther 1994;8:659-64.
  9. Ghorai M, Mandal SC, Pal M, et al. A comparative study on hypocholesterolaemic effect of allicin, whole germinated seeds of bengal gram and guggulipid of gum gugglu. Phytother.Res 2000;14:200-2.
  10. Kasliwal RR, Bansal M, Gupta R, et al. ESSENS dyslipidemia: a placebo-controlled, randomized study of a nutritional supplement containing red yeast rice in subjects with newly diagnosed dyslipidemia. Nutrition. 2016;32(7-8):767-76.
  11. Peng D, Fong A, Pelt AV. Original research: the effects of red yeast rice supplementation on cholesterol levels in adults. Am J Nurs. 2017;117(8):46-54.
  12. Alizadeh-Navaei R, Roozbeh F, Saravi M, et al. Investigation of the effect of ginger on the lipid levels. A double blind controlled clinical trial. Saudi Med J. 2008;29:1280-4.
  13. Vogler BK, Ernst E. Aloe vera: a systematic review of its clinical effectiveness. Br J Gen Pract 1999;49:823-8.
  14. Lichtenstein AH, Deckelbaum RJ. Stanol/sterol ester-containing foods and blood cholesterol levels: a statement for healthcare professionals from Nutrition Committee, Council on Nutrition, Physical Activity, Metabolism of American Heart Association. Circulation 2001;103:1177-9.
  15. Cicero, A. F., Fiorito, A., Panourgia, M. P., Sangiorgi, Z., and Gaddi, A. Effects of a new soy/beta-sitosterol supplement on plasma lipids in moderately hypercholesterolemic subjects. J Am.Diet.Assoc. 2002;102(12):1807-1811.
  16. Cicero, A. F., Minardi, M., Mirembe, S., Pedro, E., and Gaddi, A. Effects of a new low dose soy protein/beta-sitosterol association on plasma lipid levels and oxidation. Eur.J Nutr. 2004;43(5):319-322.
  17. Imai K. Nakachi K. Cross-sectional study of effects of drinking green tea on cardiovascular and liver diseases. BMJ 1995;310:693-6.
  18. Pang J, Zhang Z, Zheng TZ, et al. Green tea consumption and risk of cardiovascular and ischemic related diseases: A meta-analysis. Int J Cardiol. 2016;202:967-74.
  1. Clare BA, Conroy RS Spelman K. The diuretic effect in human subjects of an extract of Taraxacum officinale folium over a single day. J Altern Complement Med. 2009; 15(8): 929-934.
  1. Abdou AM, Higashiguchi S, Horie K, et al. Relaxation and immunity enhancement effects of gamma-aminobutyric acid (GABA) administration in humans. Biofactors 2006;26:201-8.
  2. Kahathuduwa CN, Dassanayake TL, Amarakoon AMT, Weerasinghe VS. effects of theanine, caffeine and theanine-caffeine combination on attention. Nutr Neurosci 2017;20(6):369-77.
  3. Kelly SP, Gomez-Ramirez M, Montesi JL, Foxe JJ. L-theanine and caffeine in combination affect human cognition as evidenced by oscillatory alpha-band activity and attention task performance. J Nutr 2008;138(8):1572S-1577S.
  4. Angst J, Woggon B, Schoepf J. The treatment of depression with L-5-hydroxytryptophan versus imipramine. Results of two open and one double-blind study. Arch Psychiatr Nervenkr 1977;224:175-86.
  5. Takahashi S, Kondo H, Kato N. Effect of l-5-hydroxytryptophan on brain monoamine metabolism and evaluation of its clinical effect in depressed patients. J Psychiatr Res 1975;12:177-87.
  6. Nakajima T, Kudo Y, Kaneko Z. Clinical evaluation of 5-hydroxy-L-tryptophan as an antidepressant drug. Folia Psychiatr Neurol Jpn 1978;32:223-30.
  7. Cangiano C, Ceci F, Cancino A, et al. Eating behavior and adherence to dietary prescriptions in obese adult subjects treated with 5-hydroxytryptophan. Am J Clin Nutr 1992;56:863-7.
  8. Titus F, Dávalos A, Alom J, Codina A. 5-Hydroxytryptophan versus methysergide in the prophylaxis of migraine. Randomized clinical trial. Eur Neurol 1986;25:327-9.
  9. Sarzi Puttini P, Caruso I. Primary fibromyalgia syndrome and 5-hydroxy-L-tryptophan: a 90-day open study. J Int Med Res 1992;20:182-9.
  10. Caruso I, Sarzi Puttini P, Cazzola M, Azzolini V. Double-blind study of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome. J Int Med Res 1990;18:201-9.
  11. Chen D, Liu Y, He W, Wang H, Wang Z. Neurotransmitter-precursor-supplement intervention for detoxified heroin addicts. J Huazhong Univ Sci Technolog Med Sci 2012;32(3):422-7.
  12. Kahn RS, et al. Effect of a serotonin precursor and uptake inhibitor in anxiety disorders: A double-blind comparison of 5-hydroxytryptophan, clomipramine, and placebo. International Clinical Psychopharmacology. 1987; 2(1): 33-45.
  1. Barnes S, Kim H, Darley-Usmar V, et al. Beyond ERalpha and ERbeta: Estrogen receptor binding is only part of the isoflavone story. J Nutr 2000;130:656S-7S.
  2. Ghafar MA, Golliday E, Bingham J, et al. Regression of prostate cancer following administration of genistein combined polysaccharide (GCP), a nutritional supplement: A case report. J Altern Complement Med 2002;8:493-7.
  3. Desmawati D, Sulastri D. Phytoestrogens and Their Health Effect. Open Access Maced J Med Sci. 2019 Feb 14;7(3):495-499

  1. Spelman K, Burns J, Nichols D, et al. Modulation of cytokine expression by traditional medicines: a review of herbal immunomodulators. Altern Med Rev. 2006 Jun;11(2):128-50. Review.
  2. Urdanibia I, Michelangeli F, Ruiz MC, Milano B, Taylor P. Decrease in Dengue virus-2 infection and reduction of cytokine/chemokine production by Uncaria guianensis in human hepatocyte cell line Huh-7. J Ethnopharmacol. 2013 Dec 12;150(3):1154-62. doi: 10.1016/j.jep.2013.10.055. Epub 2013 Nov 7
  3. Mello CDS, Valente LMM, Wolff T, Lima-Junior RS, Fialho LG, Marinho CF, Azeredo EL, Oliveira-Pinto LM, Pereira RCA, Siani AC, Kubelka CF. Anti-inflammatory and antitumoural effects of Uncaria guianensis bark. Mem Inst Oswaldo Cruz. 2017 Jun;112(6):458-468. doi: 10.1590/0074-02760160323.
  4. Bouie PJD, Lamprecht JH. Plant Sterols and Sterolins: A review of their immune-modulating properties. Alt Med Rev. 1999; 4(3): 170-177.
  5. Alappat L, Valerio M, Awad AB. Effect of vitamin D and Beta-sitosterol in immune function of macrophages. Elsevier. 2010; 10(11): 1390-1396.
  6. Louw, I. and et al. A pilot study of the clinical effects of a mixture of Beta-Sitosterol and Beta-Sitosterol glucoside in active rheumatoid arthritis (RA). Abstract NutritionWeek Congress 2002;
  1. Kim, Y. S. and Milner, J. A. Targets for indole-3-carbinol in cancer prevention. J.Nutr.Biochem. 2005;16(2):65-73.
  2. Anon. Indole-3-carbinol. Monograph. Alternative Medicine Review 2005;10(4):337-42.
  3. Rogan, E. G. The natural chemopreventive compound indole-3-carbinol: state of the science. In Vivo 2006;20(2):221-228.
  4. Reed GA, Peterson KS, Smith HJ, et al. A phase I study of indole-3-carbinol in women: tolerability and effects. Cancer Epidemiol Biomarkers Prev 2005;14:1953-60.
  1. Wang B, et al. Glutamine and intestinal barrier function. Amino Acids. 2015; 74(10): 2143-2154.
  2. Lee C, et al. Lupeol inhibits LPS-induced NF-kappa B signaling in intestinal epithelial cells and macrophages, and attenuates acute and chronic murine colitis. Life Sciences. 2016; 146: 100-108.
  3. Kim JS, Jobin C. The flavonoid luteolin prevents lipopolysaccharide-induced NF-kB signaling and gene expression by blocking IkB kinase activity in intestinal epithelial cells and bone-marrow derived dendritic cells. Immunology. 2005; 115(3).
  4. Zaghlool SS, et al. Protective effects of ginger and marshmallow extracts on indomethacin-induced peptic ulcer in rats. J Nat Sci Biol Med. 2015; 6(2): 421-428.
  5. Robbers JE, Tyler VE. Tyler’s Herbs of Choice: The Therapeutic Use of Phytomedicinals. New York, NY: The Haworth Herbal Press, 1999.
  6. Pierce A. The American Pharmaceutical Association Practical Guide to Natural Medicines. New York: The Stonesong Press, 1999:19.
  1. Salmi HA, Sarna S. Effect of silymarin on chemical, functional, and morphological alterations of the liver. A double-blind, controlled study. Scand J Gastroenterol 1982;17:517-21.
  2. Saller R, Brignoli R, Melzer J, Meier R. An updated systematic review with meta-analysis for the clinical evidence of silymarin. Forsch Komplementarmed 2008;15:9-20.
  3. Ferenci P, Dragosics B, Dittrich H, et al. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. J Hepatol 1989;9:105-13.
  4. Lirussi F, Nassuato G, Orlando R, and et al. Treatment of active cirrhosis with ursodeoxycholic acid and a free radical scavenger: A two year prospective study. Med Sci Ress 1995;23:31-33.
  5. Ferenci P, Dragosics B, Dittrich H, et al. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. J Hepatol 1989;9:105-13.
  6. El-Kamary, S. S., Shardell, M. D., Abdel-Hamid, M., Ismail, S., El-Ateek, M., Metwally, M., Mikhail, N., Hashem, M., Mousa, A., Aboul-Fotouh, A., El-Kassas, M., Esmat, G., and Strickland, G. T. A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis. Phytomedicine. 2009;16(5):391-400.
  7. Clare BA, Conroy RS Spelman K. The diuretic effect in human subjects of an extract of Taraxacum officinale folium over a single day. J Altern Complement Med. 2009; 15(8): 929-934.
  8. Sweeney B, Vora M, et al. Evidence-based systematic review of dandelion (Taraxacum officinale) by natural standard research collaboration. J Herb Pharmacother. 2005; 5(1): 79-93.
  9. Amalraj A, Varma K, Jacob J, et al. A novel highly bioavailable curcumin formulation improves symptoms and diagnostic indicators in rheumatoid arthritis patients: A randomized, double-blind, placebo-controlled, two-dose, three-arm, and parallel-group study. J Med Food. 2017;20(10):1022-1030.
  10. Funk, J. L., Frye, J. B., Oyarzo, J. N., Kuscuoglu, N., Wilson, J., McCaffrey, G., Stafford, G., Chen, G., Lantz, R. C., Jolad, S. D., Solyom, A. M., Kiela, P. R., and Timmermann, B. N. Efficacy and mechanism of action of turmeric supplements in the treatment of experimental arthritis. Arthritis Rheum. 2006;54(11):3452-3464.
  11. Packer L, Witt EH, Tritschler HJ. Alpha-Lipoic acid as a biological antioxidant. Free Radic Biol Med 1995;19:227-50.
  12. Constantinescu, A., Pick, U., Handelman, G. J., Haramaki, N., Han, D., Podda, M., Tritschler, H. J., and Packer, L. Reduction and transport of lipoic acid by human erythrocytes. Biochem.Pharmacol. 7-17-1995;50(2):253-261.
  13. Beitner H. Randomized, placebo controlled, double-blind study on the clinical efficacy of a cream containing 5% alpha-lipoic acid related to photoaging of facial skin. Br J Dermatol 2003;149:841-9.
  14. Lomaestro BM, Malone M. Glutathione in health and disease: pharmacotherapeutic issues. Ann Pharmacother 1995;29:1263-73.
  15. Hong SY, Gil HW, Yang JO, Lee EY, Kim HK, Kim SH, Chung YH, Hwang SK, Lee ZW. Pharmacokinetics of glutathione and its metabolites in normal subjects. J Korean Med Sci. 2005 Oct;20(5):721-6.
  16. Brok, J., Buckley, N., and Gluud, C. Interventions for paracetamol (acetaminophen) overdose. Cochrane Database.Syst.Rev. 2006;(2):CD003328.
  17. Rumack, B. H., Peterson, R. C., Koch, G. G., and Amara, I. A. Acetaminophen overdose. 662 cases with evaluation of oral acetylcysteine treatment. Arch Intern Med 2-23-1981;141(3 Spec No):380-385.
  18. Kelly GS. Clinical applications of N-acetylcysteine. Altern Med Rev 1998;3:114-27.
  19. Weinbroum AA, Rudick V, Ben-Abraham R, Karchevski E. N-acetyl-L-cysteine for preventing lung reperfusion injury after liver ischemia-reperfusion: a possible dual protective mechanism in a dose-response study. Transplantation 2000;69:853-9.
  20. Kauwell GP, Lippert BL, Wilsky CE, et al. Folate status of elderly women following moderate folate depletion responds only to a higher folate intake. J Nutr 2000;130:1584-90.
  21. Nallamothu BK, Fendrick M, Rubenfire M, et al. Potential clinical and economic effects of homocyst(e)ine lowering. Arch Intern Med 2000;160:3406-12.
  22. Homocysteine Lowering Trialists’ Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomized trials. BMJ 1998;316:894-8.
  23. Clarke R, Armitage J. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements. Semin Thromb Hemost 2000;26:341-8.
  24. Mayer O, Simon J, Rosolova H, et al. The effects of folate supplementation on some coagulation parameter and oxidative status surrogates. Eur J Clin Pharmacol 2002;58:1-5.
  25. Usui M, Matsuoka H, Miyazaki H, et al. Endothelial dysfunction by acute hyperhomocyst(e)inaemia: restoration by folic acid. Clin Sci (Colch) 1999;96:235-9.
  26. Bazzano LA, He J, Ogden LG, et al. Dietary intake of folate and risk of stroke in US men and women: NHANES I epidemiolgic follow-up study. Stroke 2002;33:1183-8..
  27. Van Guelpen B, Hultdin J, Johansson I, et al. Folate, vitamin B12, and risk of ischemic and hemorrhagic stroke: a prospective, nested case-referent study of plasma concentrations and dietary intake. Stroke 2005;36:1426-31.
  28. Upton R, ed. Schisandra Berry: Analytical, quality control, and therapeutic monograph. Santa Cruz, CA: American Herbal Pharmacopoeia 1999;1-25.
  29. Jiang W, Wang X, Xu X, Kong L. Effect of Schisandra sphenanthera extract on the concentration of tacrolimus in the blood of liver transplant patients. Int J Clin Pharmacol Ther. 2010 Mar;48(3):224-9.
  30. Narimanian, M., Badalyan, M., Panosyan, V., Gabrielyan, E., Panossian, A., Wikman, G., and Wagner, H. Impact of Chisan (ADAPT-232) on the quality-of-life and its efficacy as an adjuvant in the treatment of acute non-specific pneumonia. Phytomedicine 2005;12(10):723-729.
  1. Giovannucci E, Rimm EB, Liu Y, Stampfer MJ, Willett WC. A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst. 2002;94(5):391–98.
  2. Kritchevsky SB, Bush AJ, Pahor M, Gross MD. Serum carotenoids and markers of inflammation in nonsmokers. Am J Epidemiol. 2000;152(11):1065–71.
  3. Shen YC, Chen SL, Wang CK. Contribution of tomato phenolics to antioxidation and down-regulation of blood lipids. J Agric Food Chem. 2007;55(16):6475–81.
  4. Wood LG, Garg ML, Powell H, Gibson PG. Lycopene-rich treatments modify noneosinophilic airway inflammation in asthma: proof of concept. Free Radic Res. 2008;42(1):94–102

  1. Karzed K, Domenjoz R. Effects of Hexosamine Derivatives and Uronic Acid Derivatives on Glycosaminoglycan Metabolism of Fibroblast Cultures. Pharmocology. 1971;5:337–345.
  2. Zhu, A,. N-Acetylglucosamine for Treatment of Inflammatory Bowel Disease. Natural Medicine Journal. 2015, April 1.
  3. Rovati L, Casula P, Mascherpa S. N-Acetylglucosamine for Treating Degenerative Afflictions of the Joints. 3697652. US Patent. 1972.
  4. Tomonaga A, Watanabe K, Fukagawa M, Suzuki A, Kurokawa M, Nagaoka I. Evaluation of the effect of N-acetyl-glucosamine administration on biomarkers for cartilage metabolism in healthy individuals without symptoms of arthritis: A randomized double-blind placebo-controlled clinical study. Exp Ther Med. 2016 Sep;12(3):1481-1489

  1. Tachibana M, Mizukoshi O, Harada Y, et al. A multi-centre, double-blind study of serrapeptase versus placebo in post-antrotomy buccal swelling. Pharmatherapeutica 1984;3:526-30.
  2. Nakamura S, Hashimoto Y, Mikami M, et al. Effect of the proteolytic enzyme serrapeptase in patients with chronic airway disease. Respirology 2003;8:316-20.
  3. Mazzone A, Catalani M, Costanzo M, et al. Evaluation of Serratia peptidase in acute or chronic inflammation of otorhinolaryngology pathology: a multicentre, double-blind, randomized trial versus placebo. J Int Med Res 1990;18:379-88.
  4. Srivastava S, et al. Treatment of rheumatoid arthritis by targeting macrophages through folic acid tailored superoxide dismutase and serratiopeptidase. Journal of Drug Delivery Science and Technology. 2017; 41: 431-435.
  5. Urano T, Ihara H, Umemura K, Suzuki Y, Oike M, Akita S, Tsukamoto Y, Suzuki I, Takada A. The profibrinolytic enzyme subtilisin NAT purified from Bacillus subtilis Cleaves and inactivates plasminogen activator inhibitor type 1. J Biol Chem. 2001 Jul 6;276(27):24690-6.
  1. McIlwain H, Silverfield JC, Cheatum DE, et al. Intra-articular orgotein in osteoarthritis of the knee: a placebo-controlled efficacy, safety, and dosage comparison. Am J Med 1989;87:295-300.
  2. Gammer W, Broback LG. Clinical comparison of orgotein and methylprednisolone acetate in the treatment of osteoarthrosis of the knee joint. Scand J Rheumatol 1984;13:108-12.
  3. Giordano CR, et al. Catalse therapy corrects oxidative stress-induced pathophysiology in incipient diabetic retinopathy. Investigative Opthamology and Visual Science. 2015; 56(5): 3095-3102.
  4. Brok, J., Buckley, N., and Gluud, C. Interventions for paracetamol (acetaminophen) overdose. Cochrane Database.Syst.Rev. 2006;(2):CD003328.
  5. Rumack, B. H., Peterson, R. C., Koch, G. G., and Amara, I. A. Acetaminophen overdose. 662 cases with evaluation of oral acetylcysteine treatment. Arch Intern Med 2-23-1981;141(3 Spec No):380-385.
  6. Prescott, L. F. Treatment of severe acetaminophen poisoning with intravenous acetylcysteine. Arch Intern Med 2-23-1981;141(3 Spec No):386-389.
  7. Amagase H, Nance DM. A randomized, double-blind, placebo-controlled, clinical study of the general effects of a standardized Lycium barbarum (goji) juice, GoChi. J Altern Complement Med 2008;14:403-12.
  8. Breithaupt, D. E., Weller, P., Wolters, M., and Hahn, A. Comparison of plasma responses in human subjects after the ingestion of 3R,3R’-zeaxanthin dipalmitate from wolfberry (Lycium barbarum) and non-esterified 3R,3R’-zeaxanthin using chiral high-performance liquid chromatography. Br.J Nutr. 2004;91(5):707-713.
  9. Benzie, I. F., Chung, W. Y., Wang, J., Richelle, M., and Bucheli, P. Enhanced bioavailability of zeaxanthin in a milk-based formulation of wolfberry (Gou Qi Zi; Fructus barbarum L.). Br J Nutr 2006;96(1):154-160.
  10. Toyoda-Ono, Y., Maeda, M., Nakao, M., Yoshimura, M., Sugiura-Tomimori, N., and Fukami, H. 2-O-(beta-D-Glucopyranosyl)ascorbic acid, a novel ascorbic acid analogue isolated from Lycium fruit. J Agric Food Chem 4-7-2004;52(7):2092-2096.
  11. Moat, S. J., Ashfield-Watt, P. A., Powers, H. J., Newcombe, R. G., and McDowell, I. F. Effect of riboflavin status on the homocysteine-lowering effect of folate in relation to the MTHFR (C677T) genotype. Clin Chem 2003;49(2):295-302.
  12. McNulty, H., McKinley, M. C., Wilson, B., McPartlin, J., Strain, J. J., Weir, D. G., and Scott, J. M. Impaired functioning of thermolabile methylenetetrahydrofolate reductase is dependent on riboflavin status: implications for riboflavin requirements. Am J Clin Nutr 2002;76(2):436-441.
  13. Hustad, S., Ueland, P. M., Vollset, S. E., Zhang, Y., Bjorke-Monsen, A. L., and Schneede, J. Riboflavin as a determinant of plasma total homocysteine: effect modification by the methylenetetrahydrofolate reductase C677T polymorphism. Clin Chem 2000;46(8 Pt 1):1065-1071.
  14. Jiang Q, Christen S, Shigenaga MK, Ames BN. gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention. Am J Clin Nutr 2001;74:714-22.
  15. Wagner KH, Kamal-Eldin A, Elmadfa I. Gamma-tocopherol–an underestimated vitamin? Ann Nutr Metab 2004;48:169-88..
  16. Ferencik, M. and Ebringer, L. Modulatory effects of selenium and zinc on the immune system. Folia Microbiol.(Praha) 2003;48(3):417-426.
  17. Brown, K. M., Pickard, K., Nicol, F., Beckett, G. J., Duthie, G. G., and Arthur, J. R. Effects of organic and inorganic selenium supplementation on selenoenzyme activity in blood lymphocytes, granulocytes, platelets and erythrocytes. Clin.Sci (Lond) 2000;98(5):593-599.
  18. Celerier, P., Richard, A., Litoux, P., and Dreno, B. Modulatory effects of selenium and strontium salts on keratinocyte-derived inflammatory cytokines. Arch.Dermatol.Res. 1995;287(7):680-682.
  19. Packer L, Witt EH, Tritschler HJ. Alpha-Lipoic acid as a biological antioxidant. Free Radic Biol Med 1995;19:227-50.
  20. Constantinescu, A., Pick, U., Handelman, G. J., Haramaki, N., Han, D., Podda, M., Tritschler, H. J., and Packer, L. Reduction and transport of lipoic acid by human erythrocytes. Biochem.Pharmacol. 7-17-1995;50(2):253-261.
  21. Lomaestro BM, Malone M. Glutathione in health and disease: pharmacotherapeutic issues. Ann Pharmacother 1995;29:1263-73.
  22. Hong SY, Gil HW, Yang JO, Lee EY, Kim HK, Kim SH, Chung YH, Hwang SK, Lee ZW. Pharmacokinetics of glutathione and its metabolites in normal subjects. J Korean Med Sci. 2005 Oct;20(5):721-6.
  1. Amarowicz, R., Dykes, G. A., and Pegg, R. B. Antibacterial activity of tannin constituents from Phaseolus vulgaris, Fagoypyrum esculentum, Corylus avellana and Juglans nigra. Fitoterapia 2008;79(3):217-219.
  2. Mueller MS, et al. Randomized controlled trial of a traditional preparation of Artemisia annua L. (Annual Wormwood) in the treatment of malaria. Transactions of the Royal Society of Tropical Medicine and Hygeine. 2004; 98(5): 318-321.
  3. Amirmohammadi M, et al. In vivo evaluation of antiparasitic effects of Artemisia abrotanum and Salvia officinalis extracts on Syphacia obvelata, Aspiculoris tetrapetra, and Hymenolepis nana parasites. Asian Pac J Trop Dis. 2014; 4: S250-S254.
  4. Ledezma E, Lopez JC, Marin P, et al. Ajoene in the topical short-term treatment of tinea cruris and tinea corporis in humans. Randomized comparative study with terbinafine. Arzneimittelforschung 1999;49:544-7.
  5. Asha MK, Prashanth D, Murali B, et al. Anthelmintic activity of essential oil of Ocimum sanctum and eugenol. Fitoterapia 2001;72:669-70.
  6. Abdel-Ghaffar F, Semmler M, Al-Rasheid K, Klimpel S, Mehlhorn H. Efficacy of a grapefruit extract on head lice: a clinical trial. Parasitol Res. 2010 Jan;106(2):445-9.
  7. Kazemian A, Toghiani A, Shafiei K, et al. Evaluating the efficacy of mixture of Boswellia carterii, Zingiber officinale, and Achillea millefolium on severity of symptoms, anxiety, and depression in irritable bowel syndrome patients. J Res Med Sci. 2017;22:120.
  8. Jewell D, Young G. Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst Rev 2000;(2):CD000145.
  9. Borrelli F, Capasso R, Aviello G, et al. Effectiveness and safety of ginger in the treatment of pregnancy-induced nausea and vomiting. Obstet Gynecol 2005;105:849-56.
  10. Langmead L, Makins RJ, Rampton DS. Anti-inflammatory effects of aloe vera gel in human colorectal mucosa in vitro. Aliment Pharmacol Ther 2004;19:521-7.
  11. Molazem Z, Mohseni F, Younesi M, Keshavarzi S. Aloe vera gel and caesarean wound healing; a randomized controlled clinical trial. Glob J Health Sci 2014;7(1):203-9.
  12. Panahi Y, Davoudi SM, Sahebkar A, et al. Efficacy of Aloe vera/olive oil cream versus betamethasone cream for chronic skin lesions following sulfur mustard exposure: a randomized double-blind clinical trial. Cutan Ocul Toxicol. 2012;31:95-103.
  13. Visuthikosol V, Chowchuen B, Sukwanarat Y, et al. Effect of aloe vera gel to healing of burn wound a clinical and histologic study. J Med Assoc Thai. 1995;78:403-9.
  14. Force M, Sparks WS, Ronzio RA. Inhibition of enteric parasites by emulsified oil of oregano in vivo. Phytother Res 2000:14:213-4.
  15. Gutierrez-Grijalva EP, et al. Effect of In vitro digestion on the total antioxidant capacity and phenolic content of 3 species of oregano (Hedeoma patens, Lippia graveolens, Lippia palmeri). Journal of Food Science. 2017; 82(12): 2832-2839.
  16. Kline RM, Kline JJ, Di Palma J, Barbero GJ. Enteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children. J Pediatr 2001;138:125-8.
  17. Dew MJ, Evans BK, Rhodes J. Peppermint oil for the irritable bowel syndrome: a multicentre trial. Br J Clin Pract 1984;38:394, 398.
  18. Cappello G, Spezzaferro M, Grossi L, et al. Peppermint oil (Mintoil) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial. Dig Liver Dis 2007;39:530-6.
  19. Ruepert, L., Quartero, A. O., de Wit, N. J., van der Heijden, G. J., Rubin, G., and Muris, J. W. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2011;(8):CD003460.
  20. Madisch A, Heydenreich CJ, Wieland V, et al. Treatment of functional dyspepsia with a fixed peppermint oil and caraway oil combination preparation as compared to cisapride. A multicenter, reference-controlled, double-blind equivalence study. Arzneimittelforschung 1999;49:925-32.
  21. May B, Kuntz HD, Kieser M, Kohler S. Efficacy of a fixed peppermint oil/caraway oil combination in non-ulcer dyspepsia. Arzneimittelforschung 1996;46:1149-53.
  22. Neubauer N, Marz RW. Placebo-controlled, randomized, double-blind, clincal trial with Sinupret sugar coated tablets on the basis of a therapy with antibiotics and decongestant nasal drops in acute sinusitis. Phytomedicine 1994;1:177-81.
  23. Marz RW, Ismail C, Popp MA. Action profile and efficacy of a herbal combination preparation for the treatment of sinusitis. Wien Med Wochenschr 1999;149:202-8.
  24. Ramesh PR, Kumar KS, Rajagopal MR, et al. Managing morphine-induced constipation: a controlled comparison of an Ayurvedic formulation and senna. J Pain Symptom Manage 1998;16:240-4.
  25. MacLennan WJ, Pooler AFWM. A comparison of sodium picosulphate (“Laxoberal”) with standardised senna (“Senokot”) in geriatric patients. Curr Med Res Opin. 1974;2:641-7.
  26. Buechi, S., Vogelin, R., von Eiff, M. M., Ramos, M., and Melzer, J. Open trial to assess aspects of safety and efficacy of a combined herbal cough syrup with ivy and thyme. Forsch.Komplementarmed.Klass.Naturheilkd. 2005;12(6):328-332.
  27. Gruenwald, J., Graubaum, H. J., and Busch, R. Efficacy and tolerability of a fixed combination of thyme and primrose root in patients with acute bronchitis. A double-blind, randomized, placebo-controlled clinical trial. Arzneimittelforschung 2005;55(11):669-676.
  28. Proestos C, Chorianopoulos N, Nychas GJ, Komaitis M. RP-HPLC analysis of the phenolic compounds of plant extracts. investigation of their antioxidant capacity and antimicrobial activity. J Agric Food Chem 2005;53:1190-5..
  29. Pina-Vaz C, Goncalves Rodrigues A, Pinto E, et al. Antifungal activity of Thymus oils and their major compounds. J Eur Acad Dermatol Venereol 2004;18:73-8.
  30. Hersch-Martinez P, Leanos-Miranda BE, Solorzano-Santos F. Antibacterial effects of commercial essential oils over locally prevalent pathogenic strains in Mexico. Fitoterapia 2005;76:453-7. .
  31. Giordani R, Regli P, Kaloustian J, et al. Antifungal effect of various essential oils against Candida albicans. Potentiation of antifungal action of amphotericin B by essential oil from Thymus vulgaris. Phytother Res 2004;18:990-5.
  1. Moosavi M. Bentonite Clay as a Natural Remedy: A Brief Review. Iran J Public Health. 2017 Sep;46(9):1176-1183. PMID: 29026782; PMCID: PMC5632318.
  2. Drozdov VN, Kim VA, Tkachenko EV, Varvanina GG. Influence of a specific ginger combination on gastropathy conditions in patients with osteoarthritis of the knee or hip. J Altern Complement Med. 2012 Jun;18(6):583-8.
  3. Langmead L, Makins RJ, Rampton DS. Anti-inflammatory effects of aloe vera gel in human colorectal mucosa in vitro. Aliment Pharmacol Ther. 2004 Mar 1;19(5):521-7.
  1. Breithaupt-Grogler K, Ling M, Boudoulas H, Belz GG. Protective effect of chronic garlic intake on elastic properties of aorta in the elderly. Circulation 1997;96:2649-55.
  2. Orekhov AN, Pivovarova EM, and Tertov VV. Garlic powder tablets reduce atherogenicity of low density lipoprotein. A placebo-controlled double-blind study. Nutr Metab Cardiovascular Dis 1996;6:21-31.
  3. Orekhov AN, Sobenin IA, Korneev NV, et al. Anti-atherosclerotic therapy based on botanicals. Recent Pat Cardiovasc Drug Discov 2013;8(1):56-66.
  4. Steiner M, Khan AH, Holbert D, Lin RI. A double-blind crossover study in moderately hypercholesterolemic men that compared the effect of aged garlic extract and placebo administration on blood lipids. Am J Clin Nutr 1996;64:866-70.
  5. Holzgartner H, Schmidt U, Kuhn U. Comparison of the efficacy and tolerance of a garlic preparation vs. bezafibrate. Arzneimittelforschung 1992;42:1473-7.
  6. Rotzsch W, Richter V, Rassoul F, Walper A. [Postprandial lipemia under treatment with Allium sativum. Controlled double-blind study of subjects with reduced HDL2-cholesterol]. Arzneimittelforschung 1992;42:1223-7.
  7. Steiner M, Khan AH, Holbert D, Lin RI. A double-blind crossover study in moderately hypercholesterolemic men that compared the effect of aged garlic extract and placebo administration on blood lipids. Am J Clin Nutr 1996;64:866-70.
  8. Ried K, Frank OR, Stocks NP, et al. Effect of garlic on blood pressure: A systematic review and meta-analysis. BMC Cardiovasc Disord 2008;8:13.
  9. Vakil RJ. A clinical trial of Rauwolfia serpentina in essential hypertension. Br Heart J. 1949 Oct;11(4):350-5.
  10. Achor RW, Hanson NO, Gifford RW Jr. Hypertension treated with Rauwolfia serpentina (whole root) and with reserpine; controlled study disclosing occasional severe depression. J Am Med Assoc. 1955 Oct 29;159(9):841-5.
  11. Della, Loggia R., Tubaro, A., and Redaelli, C. [Evaluation of the activity on the mouse CNS of several plant extracts and a combination of them]. Riv.Neurol. 1981;51(5):297-310.
  12. Yarnell, E. Abascal K. Spasmolytic Botanicals: Relaxing Smooth Muscle with Herbs. Altern Complement Ther 2011;17(3):169-174.
  13. Weng WL, Zhang WQ, Liu FZ, and et al. Therapeutic effect of Crataegus pinnatifida on 46 cases of angina pectoris–a double blind study. J Tradit Chin Med 1984;4:293-94.
  14. Zapfejun G. Clinical efficacy of crataegus extract WS 1442 in congestive heart failure NYHA class II. Phytomedicine 2001;8:262-6.
  15. Pittler MH, Guo R, and Ernst E. Hawthorn extract for treating chronic heart failure. Cochrane.Database.Syst Rev 2008:CD005312.
  16. Iwamoto M, Sato T, Ishizaki T. [The clinical effect of Crataegus in heart disease of ischemic or hypertensive origin. A multicenter double-blind study]. Planta Med 1981;42:1-16.
  17. Shikov AN, Pozharitskaya ON, Makarov VG, et al. Effect of Leonurus cardiaca oil extract in patients with arterial hypertension accompanied by anxiety and sleep disorders. Phytother Res 2011;25:540-3.
  18. Sun T, Xu H, Xu F. Astragalus injection for hypertensive renal damage: a systematic review. Evidence-Based Complementary and Alternative Medicine. 2012; 929025.
  19. Li JX, et al. Antihypertensive effect of total flavonoid fraction of Astragalus complanatus in hypertensive rats. Chinese Journal of Physiology. 2005; 48(2): 101-106.
  20. Hook I, McGee A, Henman M. Evaluation of dandelion for diuretic activity and variation in Potassium content. International Journal of Pharmacognosy. 1993; 31(1): 29-34.
  21. Sweeney B, et al. Evidence-based systematic review of dandelion (Taraxacum officinale) by natural standard research collaboration. Journal of Herbal Pharmacotherapy. 2005; 5(1): 79-93.
  22. Riehemann K, Behnke B, Schulze-Osthoff K. Plant extracts from stinging nettle (Urtica dioica), and antirheumatic remedy, inhibit the proinflammtory transcription factor NF-kB. FEBS Letters. 1999; 442(1): 89-94.
  23. Rayburn, K., Fleischbein, E., Song, J., Allen, B., Kundert, M., Leiter, C., and Bush, T. Stinging nettle cream for osteoarthritis. Altern.Ther.Health Med. 2009;15(4):60-61.
  24. Chrubasik S, Enderlein W, Bauer R, and Grabner W. Evidence for antirheumatic effectiveness of Herba Urticae dioicae in acute arthritis: A pilot study. Phytomedicine 1997;4(2):105-108.
  25. Mills S, Bone K. Principles and Practice of Phytotherapy. London: Churchill Livingstone, 2000.
  26. Sanjuliani AF, de Abreu Fagundes VG, Francischetti EA. Effects of magnesium on blood pressure and intracellular ion levels of Brazilian hypertensive patients. Int J Cardiol 1996;56:177-83.
  27. Widman L, Wester PO, Stegmayr BK, et al. The dose-dependent reduction in blood pressure through administration of magnesium. A double blind placebo controlled cross-over study. Am J Hypertens 1993;6:41-5.
  28. Maxwell AJ, Zapien MP, Pearce GL, et al. Randomized trial of a medical food for the dietary management of chronic, stable angina. J Am Coll Cardiol 2002;39:37-45.
  29. Bednarz, B., Wolk, R., Chamiec, T., Herbaczynska-Cedro, K., Winek, D., and Ceremuzynski, L. Effects of oral L-arginine supplementation on exercise-induced QT dispersion and exercise tolerance in stable angina pectoris. Int.J Cardiol 9-15-2000;75(2-3):205-210.
  30. Palloshi, A., Fragasso, G., Piatti, P., Monti, L. D., Setola, E., Valsecchi, G., Galluccio, E., Chierchia, S. L., and Margonato, A. Effect of oral L-arginine on blood pressure and symptoms and endothelial function in patients with systemic hypertension, positive exercise tests, and normal coronary arteries. Am J Cardiol 4-1-2004;93(7):933-935.
  31. Huynh NT, Tayek JA. Oral arginine reduces systemic blood pressure in type 2 diabetes: its potential role in nitric oxide generation. J Am Coll Nutr 2002;21:422-7.
  32. Miguel-Carrasco JL, Mate A, Monserrat MT, Arias JL, Aramburu O, Vázquez CM. The role of inflammatory markers in the cardioprotective effect of L-carnitine in L-NAME-induced hypertension. Am J Hypertens. 2008 Nov;21(11):1231-7.
  33. Xie J, Zeng Q, Wang L. The protective effect of L-carnitine on ischemia-reperfusion heart. J Huazhong Univ Sci Technolog Med Sci. 2006;26(2):188-91.
  34. Jing L, Zhou LJ, Li WM, Zhang FM, Yuan L, Li S, Song J, Sang Y. Carnitine regulates myocardial metabolism by Peroxisome Proliferator-Activated Receptor-alpha (PPARalpha) in alcoholic cardiomyopathy. Med Sci Monit. 2011 Jan;17(1):BR1-9.
  1. Hempel S, Newberry SJ, Maher AR, Wang Z, Miles JN, Shanman R, Johnsen B, Shekelle PG. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA. 2012 9;307(18):1959-69.
  2. Goldenberg JZ, Lytvyn L, Steurich J, Parkin P, Mahant S, Johnston BC. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev. 2015;(12):CD004827.
  3. Blaabjerg S, Artzi DM, Aabenhus R. Probiotics for the Prevention of Antibiotic-Associated Diarrhea in Outpatients-A Systematic Review and Meta-Analysis. Antibiotics (Basel). 2017;6(4).
  4. Arvola T, Laiho K, Torkkeli S, et al. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics 1999;104:e64.
  5. D’Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 2002;324:1361.
  6. Videlock EJ, Cremonini F. Meta-analysis: probiotics in antibiotic-associated diarrhoea. Aliment Pharmacol Ther. 2012;35(12):1355-69.
  7. Yoshiaki O, et al. Caprylic acid in the effective treatment of intractable medical problems of frequent urination, incontinence, chronic upper respiratory infection, ALS, etc., caused by asbestos & mixed infections of Candida albicans, Helicobacter pylori & Cytomegalovirus with or without other microorganisms & Mercury. Acupuncture & Electro-Therapeutics Research. 2011; 36(1-2): 19-64.
  1. Warensjo E, Byberg L, Melhus H, et al. Dietary calcium intake and risk of fracture and osteoporosis: prospective longitudinal cohort study. BMJ 2011;342:d1473.
  2. Bryant RJ, Cadogan J, Weaver CM. The new dietary reference intakes for calcium: implications for osteoporosis. J Am Coll Nutr 1999;18:406S-412S.
  3. Welten, D. C., Kemper, H. C., Post, G. B., and van Staveren, W. A. A meta-analysis of the effect of calcium intake on bone mass in young and middle aged females and males. J Nutr 1995;125(11):2802-2813.
  4. Benevolenskaia, L. I., Toroptsova, N. V., Nikitinskaia, O. A., Sharapova, E. P., Korotkova, T. A., Rozhinskaia, L. I., Marova, E. I., Dzeranova, L. K., Molitvoslovova, N. N., Men’shikova, L. V., Grudinina, O. V., Lesniak, O. M., Evstigneeva, L. P., Smetnik, V. P., Shestakova, I. G., and Kuznetsov, S. I. [Vitrum osteomag in prevention of osteoporosis in postmenopausal women: results of the comparative open multicenter trial]. Ter.Arkh. 2004;76(11):88-93.
  5. Kruger, M. C., Schollum, L. M., Kuhn-Sherlock, B., Hestiantoro, A., Wijanto, P., Li-Yu, J., Agdeppa, I., Todd, J. M., and Eastell, R. The effect of a fortified milk drink on vitamin D status and bone turnover in post-menopausal women from South East Asia. Bone 2010;46(3):759-767.
  6. Dennehy, C. and Tsourounis, C. A review of select vitamins and minerals used by postmenopausal women. Maturitas 2010;66(4):370-380.
  7. Cosman F, de Beur SJ, LeBoff MS, et al.; National Osteoporosis Foundation. Clinician’s Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. 2014 Oct;25(10):2359-81.
  8. Chapuy MC, Pamphile R, Paris E, et al. Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos Int 2002;13:257-64..
  9. Larsen ER, Mosekilde L, Foldspang A. Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J Bone Miner Res 2004;19:370-8.
  10. Papadimitropoulos E, Wells G, Shea B, et al. Meta-analyses of therapies for postmenopausal osteoporosis. VIII: Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. Endocr Rev 2002;23:560-9.
  11. Avenell, A., Gillespie, W. J., Gillespie, L. D., and O’Connell, D. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane.Database.Syst.Rev. 2009;(2):CD000227.
  12. Iwamoto I, Kosha S, Noguchi S, et al. A longitudinal study of the effect of vitamin K2 on bone mineral density in postmenopausal women a comparative study with vitamin D3 and estrogen-progestin therapy. Maturitas 1999;31:161-4.
  13. Yonemura K, Kimura M, Miyaji T, Hishida A. Short-term effect of vitamin K administration on prednisolone-induced loss of bone mineral density in patients with chronic glomerulonephritis. Calcif Tissue Int 2000;66:123-8.
  14. Shiraki M. Vitamin K2 effects on the risk of fractures and on lumbar bone mineral density in osteoporosis – a randomized prospective open-label 3-year study. Osteoporos Int 2002;13:S160.
  15. Huang ZB, Wan SL, Lu YJ, Ning L, Liu C, Fan SW. Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a meta-analysis of randomized controlled trials. Osteoporos Int. 2015;26(3):1175-86.
  1. Gerber GS. Saw palmetto for the treatment of men with lower urinary tract symptoms. J Urol 2000;163:1408-12.
  2. Braeckman J. The extract of serenoa repens in the treatment of benign prostatic hyperplasia: a multicenter open study. Curr Ther Res 1994;55:776-85.
  3. Wilt T, Ishani A, Stark G, et al. Serenoa repens for benign prostatic hyperplasia. Cochrane Database Syst Rev 2000;(2):CD001423.
  4. Safarinejad, M. R. Urtica dioica for treatment of benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled, crossover study. J.Herb.Pharmacother. 2005;5(4):1-11.
  5. Breza J, Dzurny O, Borowka A, et al. Efficacy and acceptability of tadenan (Pygeum africanum extract) in the treatment of benign prostatic hyperplasia (BPH): a multicentre trial in central Europe. Curr Med Res Opin 1998;14:127-39.
  6. Andro MC, Riffaud JP. Pygeum africanum extract for the treatment of patients with benign prostatic hyperplasia. A review of 25 years of published experience. Curr Ther Res 1995;56:796-817.
  7. Wilt T, Ishani A, Mac Donald R, et al. Pygeum africanum for benign prostatic hyperplasia. Cochrane Database Syst Rev 2002;CD001044..
  8. Mahmoud AM, Al-Alem U, Dabbous F, et al. Zinc intake and risk of prostate cancer: Case-control study and meta-analysis. PLoS One. 2016;11(11):e0165956.
  9. Wang, C. H., Fang, C. C., Chen, N. C., Liu, S. S., Yu, P. H., Wu, T. Y., Chen, W. T., Lee, C. C., and Chen, S. C. Cranberry-containing products for prevention of urinary tract infections in susceptible populations: a systematic review and meta-analysis of randomized controlled trials. Arch Intern.Med 7-9-2012;172(13):988-996.
  10. Luís Â, Domingues F, Pereira L. Can cranberries contribute to reduce the incidence of urinary tract infections? – A systematic review with meta-analysis and trial sequential analysis of clinical trials. J Urol. 2017.
  11. Zhang L, Hasegawa I, Ohta T. Anti-inflammatory cyclopentene derivatives from the inner bark of Tabebuia avellanedae. Fitoterapia 2016;109:217-23.
  12. de Almeida ER, da Silva Filho AA, dos Santos ER, Lopes CA. Antiinflammatory action of lapachol. J Ethnopharmacol. 1990 ;29(2):239-41.
  13. Clinton SK, Emenhiser C, Schwartz SJ, et al. Cis-trans lycopene isomers, carotenoids, and retinol in the human prostate. Cancer Epidemiol Biomarkers Prev 1996;5:823-33.
  14. Giovannucci E, Ascherio A, Rimm EB, et al. Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 1995;87:1767-76.
  15. Norrish AE, Jackson RT, Sharpe SJ, Skeaff CM. Prostate cancer and dietary carotenoids. Am J Epidemiol 2000;151:119-23.
  16. Rao, A. V., Fleshner, N., and Agarwal, S. Serum and tissue lycopene and biomarkers of oxidation in prostate cancer patients: a case-control study. Nutr Cancer 1999;33(2):159-164.
  17. Gupta I, Parihar A, Malhotra P, et al. Effects of Boswellia serrata gum resin in patients with ulcerative colitis. Eur J Med Res 1997;2:37-43.
  18. Amalraj A, Varma K, Jacob J, et al. A novel highly bioavailable curcumin formulation improves symptoms and diagnostic indicators in rheumatoid arthritis patients: A randomized, double-blind, placebo-controlled, two-dose, three-arm, and parallel-group study. J Med Food. 2017;20(10):1022-1030.
  19. Funk, J. L., Frye, J. B., Oyarzo, J. N., Kuscuoglu, N., Wilson, J., McCaffrey, G., Stafford, G., Chen, G., Lantz, R. C., Jolad, S. D., Solyom, A. M., Kiela, P. R., and Timmermann, B. N. Efficacy and mechanism of action of turmeric supplements in the treatment of experimental arthritis. Arthritis Rheum. 2006;54(11):3452-3464.
  20. Belcaro G, Cesarone MR, Dugall M, et al. Efficacy and safety of Meriva, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. Alt Med Rev 2010:15:337-4.
  21. Belcaro, G., Cesarone, M. R., Dugall, M., Pellegrini, L., Ledda, A., Grossi, M. G., Togni, S., and Appendino, G. Product-evaluation registry of Meriva(R), a curcumin-phosphatidylcholine complex, for the complementary management of osteoarthritis. Panminerva Med 2010;52(2 Suppl 1):55-62.
  22. Hee-ju P, Chang-Min L, In Duk J, et al. Quercetin regulates Th1/Th2 balance in a murine model of asthma. International Immunopharmacology. 2009; 9(3): 261-267.
  23. Rogerio AP, Kanashiro C, et al. Anti-inflammatory activity of quercetin and isoquercetin in experimental murine allergic asthma. Inflammation Research. 2007; 56(10): 402-408.
  24. Joskova M, Franova S, Sadlonova V. Acute bronchodilator effect of quercetin in experimental allergic asthma. Brastisl Lek Listy. 2011; 112(1): 9-12.
  1. Yago MR, Frymoyer A, Benet LZ, Smelick GS, Frassetto LA, Ding X, Dean B, Salphati L, Budha N, Jin JY, Dresser MJ, Ware JA. The use of betaine HCl to enhance dasatinib absorption in healthy volunteers with rabeprazole-induced hypochlorhydria. AAPS J. 2014 Nov;16(6):1358-65.
  2. Yago MR, Frymoyer AR, Smelick GS, Frassetto LA, Budha NR, Dresser MJ, Ware JA, Benet LZ. Gastric reacidification with betaine HCl in healthy volunteers with rabeprazole-induced hypochlorhydria. Mol Pharm. 2013 Nov 4;10(11):4032-7.
  3. McShane P, et al. Protease activity in pancreatic islet isolation by enzymatic digestion. Diabetes. 1989; 38: 126-128.
  4. Owen G, Peters TJ, Dawson S, Goodchild MC. Pancreatic enzyme supplement dosage in cystic fibrosis. Lancet 1991;338:1153.
  5. Stern RC, Eisenberg JD, Wagener JS, et al. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency. Am J Gastroenterol 2000;95:1932-8.
  6. Van der Maarel MJEC, et al. Properties and applications of starch-converting enzymes of the alpha-amylase family. Journal of Biotechnology. 2002; 94: 137-155.
  7. Ghose TK. Measurement of cellulase activities. 2009; 59(2): 257-268.
  8. Sanders SW, Tolman KG, Reitberg DP. Effect of a single dose of lactase on symptoms and expired hydrogen after lactose challenge in lactose-intolerant subjects. Clin Pharm 1992;11:533-8..
  9. Lin MY, Dipalma JA, Martini MC, et al. Comparative effects of exogenous lactase (beta-galactosidase) preparations on in vivo lactose digestion. Dig Dis Sci 1993;38:2022-7..
  10. Monaghan PJ, Leys D, Scrutton NS. Mechanistic aspects and redox properties of hyperthermophilic L-proline dehydrogenase from Pyrococcus furiosus related to dimethylglycine dehydrogenase/oxidase. The FEBS Journal. 2007; 274(8)
  1. Shen, Z., Yu, P., Sun, M., and et al. [A prospective study on Zhitai capsule in the treatment of primary hyperlipidemia] (Translation). National Medical Journal of China 1996;76(2):156-158.
  2. Kasliwal RR, Bansal M, Gupta R, et al. ESSENS dyslipidemia: a placebo-controlled, randomized study of a nutritional supplement containing red yeast rice in subjects with newly diagnosed dyslipidemia. Nutrition. 2016;32(7-8):767-76. doi: 10.1016/j.nut.2016.01.012.
  3. Peng D, Fong A, Pelt AV. Original research: the effects of red yeast rice supplementation on cholesterol levels in adults. Am J Nurs. 2017;117(8):46-54. doi: 10.1097/01.NAJ.0000521973.38717.2e.
  4. Gerards MC, Terlou RJ, Yu H, Koks CH, Gerdes VE. Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain – a systematic review and meta-analysis. Atherosclerosis. 2015;240(2):415-23. doi: 10.1016/j.atherosclerosis.2015.04.004.
  5. Lu, Z., Kou, W., Du, B., Wu, Y., Zhao, S., Brusco, O. A., Morgan, J. M., Capuzzi, D. M., and Li, S. Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction. Am J Cardiol 2008;101(12):1689-1693.
  6. Li, J. J., Lu, Z. L., Kou, W. R., Chen, Z., Wu, Y. F., Yu, X. H., and Zhao, Y. C. Beneficial impact of Xuezhikang on cardiovascular events and mortality in elderly hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS). J Clin Pharmacol 2009;49(8):947-956.
  1. Papakostas GI, Mischoulon D, Shyu I, et al. S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial. Am J Psychiatry 2010;167:942-8
  2. Bottiglieri T, Hyland K, Reynolds EH. The clinical potential of ademetionine (S-adenosylmethionine) in neurological disorders. Drugs 1994;48:137-52
  3. Bottiglieri T. S-Adenosyl-L-methionine (SAMe): from the bench to the bedside–molecular basis of a pleiotrophic molecule. Am J Clin Nutr 2002;76:1151S-7S
  4. Kadakia KC, Loprinzi CL, Atherton PJ, Fee-Schroeder KC, Sood A, Barton DL. Phase II evaluation of S-adenosyl-L-methionine (SAMe) for the treatment of hot flashes. Support Care Cancer. 2016;24(3):1061-9
  5. Bradley JD, Flusser D, Katz BP, et al. A randomized, double blind, placebo controlled trial of intravenous loading with S-adenosylmethionine (SAM) followed by oral SAM therapy in patients with knee osteoarthritis. J Rheumatol 1994;21:905-11
  6. Konig B. A long-term (two years) clinical trial with S-adenosylmethionine for the treatment of osteoarthritis. Am J Med 1987;83:89-94
  7. Najm WI, Reinsch S, Hoehler F, et al. S-adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: A double-blind crossover trial. BMC Musculoskelet Disord 2004;5:6
  8. Work Group for Major Depressive Disorder. Practice Guideline for the Treatment of Patients With Major Depressive Disorder, Third Edition. American Psychiatric Association, May 2010 (Published October 2010). Available at: http://www.psych.org/guidelines/mdd2010
  9. Ravindran AV, Balneaves LG, Faulkner G, et al.; CANMAT Depression Work Group. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine Treatments. Can J Psychiatry 2016;61(9):576-87

  1. Martin NG, Carr AB, Oakeshott JG, Clark P. Co-twin control studies: vitamin C and the common cold. Prog Clin Biol Res 1982;103:365-73
  2. Levine M, Rumsey SC, Daruwala R, et al. Criteria and recommendations for vitamin C intake. JAMA 1999;281:1415-23
  3. Wen Y, Li L, Deng Z. Calcitriol supplementation accelerates the recovery of patients with tuberculosis who have vitamin D deficiency: a randomized, single-blind, controlled clinical trial. BMC Infect Dis 2022;22(1):436.
  4. Karonova TL, Golovatyuk KA, Kudryavtsev IV, et al. Effect of cholecalciferol supplementation on the clinical features and inflammatory markers in hospitalized COVID-19 patients: A randomized, open-label, single-center study. Nutrients 2022;14(13):2602
  5. Mossad SB, Macknin ML, Medendorp SV, Mason P. Zinc gluconate lozenges for treating the common cold. A randomized, double-blind, placebo-controlled study. Ann Intern Med 1996;125:81-8
  6. Al Sulaiman K, Aljuhani O, Al Shaya AI, et al. Evaluation of zinc sulfate as an adjunctive therapy in COVID-19 critically ill patients: a two-center propensity-score matched study. Crit Care. 2021;25(1):363
  7. Shankar AH, Prasad AS. Zinc and immune function: the biological basis of altered resistance to infection. Am J Clin Nutr 1998;68:447S-63S.
  8. Nieman DC, Henson DA, Gross SJ, et al. Quercetin reduces illness but not immune perturbations after intensive exercise. Med Sci Sports Exerc 2007;39:1561-9
  9. Nieman DC, Henson DA, Davis JM, et al. Quercetin’s influence on exercise-induced changes in plasma cytokines and muscle and leukocyte cytokine mRNA. J Appl Physiol 2007;103:1728-3
  10. Otsuka H, Inaba M, Fujikura T, Kunitomo M. Histochemical and functional characteristics of metachromatic cells in the nasal epithelium in allergic rhinitis: studies of nasal scrapings and their dispersed cells. J Allergy Clin Immunol 1995;96:528-36.
  11. Percival SS. Copper and immunity. Am J Clin Nutr. 1998 May;67(5 Suppl):1064S-1068S. doi: 10.1093/ajcn/67.5.1064S. PMID: 9587153.
  12. Djoko KY, Ong CL, Walker MJ, McEwan AG. The Role of Copper and Zinc Toxicity in Innate Immune Defense against Bacterial Pathogens. J Biol Chem. 2015 Jul 31;290(31):18954-61.

  1. Schlebusch L, et al. A double-blind, placebo-controlled, double-centre study of the effects of an oral multivitamin-mineral combination on stress. South African Medical Journal. 2000; 90(12): 1216-1223.
  2. Monaghan PJ, Leys D, Scrutton NS. Mechanistic aspects and redox properties of hyperthermophilic L-proline dehydrogenase from Pyrococcus furiosus related to dimethylglycine dehydrogenase/oxidase. The FEBS Journal. 2007; 274(8)
  1. Hempel S, Newberry SJ, Maher AR, Wang Z, Miles JN, Shanman R, Johnsen B, Shekelle PG. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA. 2012 9;307(18):1959-69.
  2. Goldenberg JZ, Lytvyn L, Steurich J, Parkin P, Mahant S, Johnston BC. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev. 2015;(12):CD004827.
  3. Blaabjerg S, Artzi DM, Aabenhus R. Probiotics for the Prevention of Antibiotic-Associated Diarrhea in Outpatients-A Systematic Review and Meta-Analysis. Antibiotics (Basel). 2017;6(4).
  4. Arvola T, Laiho K, Torkkeli S, et al. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics 1999;104:e64.
  5. D’Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 2002;324:1361.
  6. Videlock EJ, Cremonini F. Meta-analysis: probiotics in antibiotic-associated diarrhoea. Aliment Pharmacol Ther. 2012;35(12):1355-69.

We Do Not Accept Illness! ... and neither should you

Call us today

Links
Account
Saskatoon, SK
Facebook Instagram Youtube
Melfort, SK
Facebook Instagram Youtube
Medicine Hat, AB
Facebook Instagram Youtube
©2024 Choice Nutrition Centres Inc. | Web Design Saskatoon by Zeal Media